KCNQ1 Gene Short QT Syndrome Type 2 NGS Genetic DNA Test
Comprehensive Genetic Testing for Cardiac Arrhythmia Risk
The KCNQ1 Gene Short QT Syndrome Type 2 NGS Genetic DNA Test represents a breakthrough in cardiac genetic medicine, offering precise detection of mutations associated with a rare but potentially fatal heart condition. This advanced diagnostic tool utilizes cutting-edge Next-Generation Sequencing technology to analyze the KCNQ1 gene, providing crucial insights into inherited cardiac risk factors that could otherwise remain undetected until a serious cardiac event occurs.
What This Test Measures and Detects
This specialized genetic test specifically targets the KCNQ1 gene, which encodes a critical potassium channel protein essential for proper cardiac electrical activity. The test identifies:
- Pathogenic variants in the KCNQ1 gene associated with Short QT Syndrome Type 2
- Specific mutations affecting cardiac repolarization processes
- Genetic markers for increased risk of ventricular arrhythmias
- Inherited patterns of cardiac electrical abnormalities
- Variants that disrupt normal potassium channel function
Who Should Consider This Genetic Test
This test is particularly recommended for individuals experiencing:
- Unexplained syncope (fainting episodes) without clear cause
- Family history of sudden cardiac death or unexplained cardiac events
- Abnormal ECG findings showing shortened QT intervals
- Palpitations or irregular heart rhythms without diagnosed cause
- Previous diagnosis of cardiac arrhythmia without identified trigger
- Family members of individuals with confirmed Short QT Syndrome
- Young athletes with cardiac symptoms or family cardiac history
Significant Benefits of Genetic Testing
Undergoing the KCNQ1 genetic test provides numerous advantages for cardiac health management:
- Early Risk Identification: Detect genetic predisposition before symptoms manifest
- Personalized Treatment Planning: Enable targeted therapeutic interventions
- Family Screening Guidance: Identify at-risk relatives for proactive monitoring
- Informed Lifestyle Decisions: Make educated choices about physical activities and medications
- Reproductive Planning: Understand inheritance patterns for family planning
- Peace of Mind: Reduce uncertainty about cardiac health status
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert genetic counselors and cardiologists:
- Positive Result: Indicates presence of a pathogenic KCNQ1 variant requiring cardiac specialist consultation and potential intervention strategies
- Negative Result: Suggests absence of tested mutations, though continued cardiac monitoring may be recommended based on clinical presentation
- Variant of Uncertain Significance: Requires additional family studies and ongoing research correlation
- Comprehensive Report: Includes detailed variant analysis, clinical correlations, and management recommendations
Test Pricing Information
| Test Component | Price (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly offer comprehensive genetic testing services across the United States with convenient locations in major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art laboratories ensure consistent, reliable results regardless of testing location.
Take Control of Your Cardiac Health Today
Don’t wait for symptoms to manifest before addressing potential cardiac genetic risks. Our KCNQ1 Gene Short QT Syndrome Type 2 NGS Genetic DNA Test provides the critical information needed for proactive cardiac health management. With results available in 3-4 weeks and multiple sample collection options including blood, extracted DNA, or FTA card blood spots, getting tested has never been more convenient.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your test. Our dedicated team is ready to guide you through every step of the testing process and help you understand your results for better cardiac health outcomes.
